Pestilence, plague, bioterrorism / Paul F. Torrence -- Viral bioterrorism and antiviral countermeasures / Mike Bray -- Overview of antiviral drug discovery and development / Christopher K. Tseng -- Antiviral drug targets and strategies for emerging viral diseases and bioterrorism threats / Erik De Clercq -- Perspectives for the therapy against arenavirus infections / Elsa B. Damonte and Cybele C. García -- S-adenosylhomocysteine hydrolase inhibitors as a source of anti-filovirus agents / Stewart W. Schneller and Minmin Yang -- Antiviral strategies for Ebola virus / Jillian M. Licata and Ronald N. Harty -- IMPDH inhibitors: discovery of antiviral agents against emerging diseases / Vasu Nair -- Lethal mutagenesis: exploiting error-prone replication of riboviruses for antiviral therapy / Jason D. Graci and Craig E. Cameron -- Structural biology of flavivral replication and opportunities for drug design / Krishna Murthy --

Confronting new and old antiviral threats: broad spectrum potential of prenylation inhibitors / Menashe Elazar and Jeffrey S. Glenn -- West Nile virus: new targets for potential antivirals / Matthias Kalitzky, Holger Rohde, and Peter Borowski -- The emergence of pandemic influenza A: bioterrorist versus mother nature / John S. Oxford ... [et al.] -- Discovery and development of new antivirals for smallpox / Earl R. Kern -- Viral countermeasures to the host interferon response: role of the vaccinia virus E3L and K3L genes / Jeffrey O. Langland, Vanessa Lancaster, and Bertram L. Jacobs -- Broad-sprectrum antiviral prophylaxis: inhibition of viral infection of polymer grafting with methoxypoly(ethylene glycol) / Lori L. McCoy and Mark D. Scott -- Viral evasion of the interferon system: novel targets for drug discovery / Paul F. Torrence and Linda Powell.